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Incisional hernias are a common clinical problem occurring in up to 10% of all 
patients undergoing abdominal incisions.  Current repair techniques involve the 
placement of xenografts, allografts, or prosthetic biomaterials.  Despite these 
techniques, the incidence of hernia recurrence ranges from 24% to 54%.  In order to 
address these high recurrence rates, we propose using a skeletal muscle engineering 
strategy.  To this end, the novel cyclic acetal biomaterial, 5-ethyl-5-(hydroxymethyl)-
β,β-dimethyl-1,3-dioxane-2-ethanol diacrylate, was functionalized to promote skeletal 
muscle regeneration.  It was found that this biomaterial promotes myoblastic cell 
attachment and proliferation as well as the delivery of functional insulin-like growth 
factor 1 proteins in vitro; therefore demonstrating the scaffolds biocompatibility.  
Furthermore, mechanical properties of the scaffold were tested and the complex 
modulus was shown to decrease after a significant increase in initiator concentration.  
Overall, this work establishes the functionality of a degradable cyclic acetal as a 
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Chapter 1: Introduction 
  
In 2004, the Society of American Gasterointestinal and Endoscopic Surgeons 
reported that approximately 600,000 hernia repair surgeries are performed every year 
in the United States.1-4 Epigastric, umbilical, inguinal and femeral hernias are all 
included in these figures, however the most prominent is the ventral or incisional 
hernia as they account for 36 percent of all hernia repairs with this number increasing 
every year.2 Incisional hernias develop when the skeletal muscle around an incision 
site is weakened such that it can no longer support the pressure exerted by the internal 
organs causing a rupture.  This occurs in up to one out of every five patients that 
undergo abdominal incisions.  With these overwhelming numbers, abdominal hernias 
are among the most common pathological conditions that afflict humans. Still, it is 
believed that these numbers are underestimated. 5, 6 
Once rupture occurs a portion of the abdominal viscera can become confined 
or entrapped in the defect leading to two common physical symptoms: pain and a 
visible protrusion.  Viscera, such as the bowel, often get trapped in these abdominal 
defects, occasionally with grave consequences.  When entrapment does occur, there is 
potential for strangulation, ischemia and possible necrosis of the viscera.  If left 
untreated the end result could be the loss of the organ or possibly the death of the 
patient.   
 Current treatment methods for abdominal wall hernias involve pressure 





Despite these available techniques, the incidence of recurrence ranges from 24 to 
54%, still making hernia repair a matter of concern for today’s clinicians.7  
 To address the clinical need for better hernia repair strategies tissue 
engineering approaches have been proposed.  By using engineering methodologies to 
study the structure-function relationship inherent in normal and pathological 
mammalian tissues, one can create biological substitutes to restore, maintain or 
improve tissue function.8 Only through the combination of the system’s functional 
biology (cell to cell signaling) with the systems interaction characteristics (scaffolds) 
can methods or tissues be produced that can replicate or improve that found naturally.   
To begin developing an alternative strategy for abdominal wall hernia repair, 
the interactions between a skeletal myoblastic cell population and a novel 
biodegradable scaffold made from 5-ethyl-5-(hydroxymethyl)-β,β-dimethyl-1,3-
dioxane-2-ethanol diacrylate (EHD) were studied.  Three aspects of these scaffolds 
were investigated: mechanical properties, myoblastic cell compatibility and protein 
interactions.  First, to determine the mechanical properties of the crosslinked EH 
networks; the effect of initiator concentration on the complex modulus was examined.  
Second, by investigating the effect of initiator concentration on myoblastic cell 
attachment, the cellular compatibility of the network was determined.  Third, once it 
was found that this network was a viable scaffold, the protein interactions were 
studied, specifically, the signaling pathways and delivery of insulin-like growth factor 
- 1  (IGF-1).  The ability of a myoblastic cell population to maintain the IGF-1 
signaling pathways while attached to the EH scaffolds was determined by studying 





attached myoblasts.  In further protein interaction studies, delivery of the IGF-1 was 
achieved through physical adsorption upon the scaffold surface.  To quantify the IGF-
1 delivery, the effects of increasing adsorbed IGF-1 concentrations on the release rate 






Chapter 2: Tissue Engineering Approaches to Abdominal Wall 
Hernias 
 
2.1 Abdominal Wall Physiology 
2.1.1 Hernias and the Abdominal Wall Physiology 
An incisional hernia has been defined as a breakdown or loss of continuity of 
a fascial closure.9 A discontinuity in the musculature can result from injuries or 
traumas, occurring by both direct or indirect means, as well as disease, aging, or a 
weakness from birth.4 With direct injuries, an object, such as a scalpel or a bullet, 
pierces the musculature layer creating the defect.9 Indirect injuries, on the other hand, 
occur when an object hits the body with enough force to create a defect without 
affecting the other layers of the abdomen; an example being a cyclist coming in 
contact with the bicycle handlebars during a crash.10 While direct injuries may 
involve more layers of tissue, it is the inability of the muscle to heal itself, in both 
cases, that leave the defect open and at risk. 
The abdominal wall is made up of six layers: skin, subcutaneous fascia, 
musculature, transversalis fascia, preperitoneal tissue and peritoneum.11, 12 Skin is 
composed of two layers: the dermis or corium and the epidermis.  The dermis itself 
also contains two layers: the papillary and the reticular layers.  Functioning as a 
connective layer, the papillary layer contains loose connective tissue that attaches to 
the epidermis.  Beneath this, the reticular layer contains the capillaries, lymphatics, 
and nerve ending, as well as, the hair follicles, sebaceous glands, sweat glands and 
their ducts, and smooth muscle fibers.  All of these elements are supported by a 





made up of nonvascularized endothelial cells that form from the inside outward.13 
Together these layers range in thickness from 1-3mm.14  
Adipose and connective tissue make up the subcutaneous fascia, transversalis 
fascia and preperitoneal tissue.  All three layers contain fat cells and fat stores to 
varying degrees.  The subcutaneous fascia layer varies in thickness from 0.5-6cm and 
changes gradually with position along the abdomen.14 The skin thickness, the quantity 
of fat cells and the amount of fat stored in these layers also varies dependently on the 
individual. 
The musculature is made up of the transverus adbominis, internal oblique, 
external oblique and rectus abdominis.11 Each muscle has a contralateral mirror 
image, with each individual group having a unique arrangement of the muscle fibers.  
The fibers are arranged based on the group’s functionality and these bundles provide 
strength to the abdominal wall.  The peritoneum lines the inside of the abdominal 
cavity, effectively containing the abdominal organs, which contains folds that vary in 
thickness throughout the abdominal cavity. 
All of these layers are involved in hernia occurrence and repair to varying 
degrees, based on the injury sustained.  Hernia repair research focuses mainly on the 
musculature and peritoneum, as they and the incorporated aponeuroses and muscular 
fasciae are the most affected.   
 
2.1.2 Abdominal Wall Functionality 
The critical function of the abdominal wall is to counteract the large pressure 





exploit the smallest weakness or disruption in the musculature.  Many everyday 
activities are associated with a significant increase in this internal pressure force; 
laughing, coughing, vomiting, heavy physical exercise, or even just lifting your head 
and legs, standing or sitting upright can have an effect.4, 5, 9 When this weakness is 
exploited, the musculature can bulge or tear, consequentially relieving the built up 
pressure and creating a hernia.  Depending on the size of the resulting hernia, 
symptoms may or may not be present.  Some of the symptoms include: pain 
(especially in bending), intestinal obstruction or the presence of a visible bulge where 
the hernia sac is present.6, 9 Clinicians have various tools to diagnose hernias, 
including physical exams, ultrasound, CT (computer tomography) scans or any 
combination of the above.6, 7, 9, 14, 15  
 
2.2 Herniation 
2.2.1 A Mechanism for Herniation 
Several factors, including those that are patient oriented and others that are 
clinically based, increase the probability of an initial herniation as well as a hernia 
recurrence.  A study of 850 hernia repair patients found that the average age of 
patients undergoing hernia repair surgeries was 54, with the ages ranging from as 
young as 13 to as old as 94.  In addition, the study showed that patients with a body 
mass index greater than 40 were more susceptible to complications, longer surgery 
times, larger defects and a higher recurrence rate.16  
When isolating the data for incisional hernias specifically, it was found that 





shown a greater propensity for occurrence and recurrence.5, 7, 9 Medical conditions 
such as constipation, prostatism, diabetes mellitus, pulmonary diseases, jaundice and 
several more have also been found to increase the probability of herniation.5, 7, 9  Each 
on its own can result in hernia development, but a combination of any of these risk 
factors can be detrimental.  Furthermore, it has been found that incision and suture 
procedures, in addition to suture or prosthetic material choices and wound infection 
affect the probability of herniation.9 
Two types of incisions used in skeletal muscle surgeries are vertical and 
transverse incisions.  Sutures used to closed these incisions exert an increased tension 
force on a small area in the muscle sometimes leading to pull through; especially in 
vertical incisions.9 To alleviate this tension and limit pull through different suture 
procedures have been utilized; two of the most common are the interrupted and 
continuous suture techniques.9 The interrupted suture technique is used occasionally, 
however, it is associated with higher tension in the defect, therefore increasing the 
likelihood of recurrence.  This occurs if the sutures do not have uniform tautness or 
are not evenly spaced, leading to a risk of fascial necrosis.  So to eliminate this effect, 
continuous suture techniques are used to evenly disperse the tension over the entire 
wound.9 Suture materials and wound healing effects are discussed in a later section. 
 
2.3 Overview of Current Clinical Solutions 
2.3.1 Clinical Approaches to Treating Abdominal Hernias 
Due to the fact the abdominal wall hernias are so inconsistent in size, shape, 





abdominal hernias. Techniques such as pressure trusses, sutures, the placement of a 
prosthetic biomaterial meshes, xenografts or allografts are all valid options.6, 17 With 
the exception of pressure trusses, all of these techniques require a surgical procedure.  
Pressure trusses apply mechanical force to the herniated area to close the defect.  
They are only used in patients with excessively large defects who are not suitable 
surgical candidates and are rarely used in developed countries. 
The recurrence rate for suture only techniques is approximately 45%; 
recurrence is defined by the reopening of a previously treated abdominal defect.7 
Using sutures alone in smaller hernias, which exhibit less tension, is a viable option, 
however when the defect size increases thus increasing suture tension, pull through 
becomes more common.  Such high recurrence rates have prompted the development 
and advancement of a generation of tissue engineering grafts that help aid in the 
support of the surrounding tissue.  Still, these materials must be secured to the 
abdominal wall to be effective and thus can harbor some of the same concerns as 
suture techniques.  To help alleviate this complication current meshes are attached 
using “tension free” methods.  In addition to lowering recurrence rates as much as 
75%, tension free suturing also helps to decrease healing time and pain.  This alone 
does not completely correct the problem as the overall recurrence rate is still 
approximately 24%.7, 15, 18-20 
 
2.3.2 Criteria for Repair Techniques 
To be considered viable for clinical application, there are several criteria that 





allow for the return of functionality to the tissue.  In skeletal muscle, pliancy and 
mechanical strength are particularly significant.  An implant must be able to move 
with the body to prevent additional stress and tension on the supporting tissue, as well 
as, the implant itself.  Additionally, the implant must be able to withstand the 
changing pressure exerted by the internal organs.  Anything weaker or less pliable 
than the native tissue could potentially increased risk of recurrence as well as affect 
the surrounding tissues.  
System reactions are the second criteria.  Wound healing plays an important 
role in the regaining of functional tissue.  It has been shown that devices that can 
decrease the inflammatory respond and body rejection to an implant or suture are 
better candidates for repair.21 Concurrently, any material that supports the growth of 
bacteria or the harboring of other harmful microorganisms would be detrimental to 
the wound healing process.  Therefore, the tissue or prosthesis used would ideally 
support the ingrowth of the native tissue to regenerate the muscle without supporting 
the growth of harmful microorganisms.  It should also limit adhesions of the 
abdominal viscera, as these adhesions are the leading cause of intestinal obstructions, 
as well as, they are responsible for chronic abdominal pain and 15-20% of cases of 
female infertility.21  
One major setback to the biomaterials used today is that they are left in the 
body permanently, making it possible for the implant to migrate or shrink thus 
rendering it ineffective.22 Therefore implants and suture materials that have the 
additional property of being absorbable are being studied.  Being biodegradable 





grow into the defect.  Optimization of all of these properties would give the ideal 
device for hernia repair. 
 
2.3.3 Xenografts 
In the beginning xenografts were used primarily as suture material.  Tissues 
such as kangaroo, ox, deer and whale tendons have all been utilized.18 Catgut was 
also a common tissue used primarily to form suture materials.  As the high recurrence 
rates of suture techniques have become more evident, patches have become more 
popular.  Porcine small intestine submucosa (SIS) is being studied as a viable tissue 
patch.  Taken from the small intestine of a pig, the cells are removed from the layers 
of tissue, leaving behind the extracelluar matrix’s (ECM) supporting structure.  
Layers can then be combined as needed to increase the strength and size of the 
scaffold.  Once implanted, this scaffold attracts host cells and begins to reorganize 
them in such a way that connective tissue fills the defect.  An additional benefit to 
this graft is that over time it is reabsorbed into the body leaving behind only host 
tissue.23, 24 
While all these materials help restore some functionality of the muscle there 
are two major limitations: disease transmission and host rejection.  Several tests that 
are used to screen donor tissues for disease only test for known or prevalent diseases.  
This could leave the tissue unusable.  Host rejection is an equally troublesome 
limitation.  If the host’s body attacks the implant, the graft could become 
compromised and the defect will remain.  Methods such as removing the cells of the 






Allografts are similar to xenografts and are especially useful because the 
donor tissues are more comparable to host tissues.  They can be utilized in two ways.  
The first is as a whole tissue graft.  This provides both a cellular component (for 
tissue regeneration) and the ECM component (a scaffold for host and donor cells).  
Another option is to separate the cellular component from the ECM and use them 
separately.  The cells can be utilized in various therapeutic techniques and the ECM 
can be implanted as an acellular scaffold.25   
However, the core limitation of this technique is availability.  There is a limit 
to how much tissue can be extracted from a donor without causing a defect that is of a 
critical size in which it does not heal itself.  As with the xenografts, host rejection is 
still an issue; however the disease transmission risk is considerably lower.  
 
2.3.5 Prosthetic Meshes 
The placement of prosthetic meshes into defects is becoming a more frequent 
alternative to tissue implants as the number of biocompatible materials is increasing.  
These meshes give a greater control over the implant properties.  Two common 
synthetic polymers that have been used extensively are polytetrafluoroethylene 
(PTFE) and polypropylene (PP).  Natural polymers such as sodium hyaluronate (HA) 
and carboxymethylcellulose (CMC) are also used.  By varying percentages of 
different monomers along with the crosslink density of the polymer, one can change 
the biodegradability and pliability of the resulting material.  In addition, when 





achieved.  Not only can pore sizes be controlled but pore shapes can be altered and 
their distribution can be in either random or in ordered patterns.21, 26 These processing 
techniques provide an added control over the mechanical and biological properties of 
the resulting material.  Furthermore, these materials do not present the same risk for 
disease transmission due to the lack of a previous cellular component. 
Biomaterials, unlike donor tissues or cells, are not limited in quantity or 
quality. With a larger supply of materials, defects of a larger size can be treated more 
effectively than with donor tissue.  This technique is not without its drawbacks, 
however.  To the body, the implant is seen as a foreign object; the risk of eliciting an 
inflammatory response is eminent.  In abdominal hernias, fibrosis occurs and can 
provoke adhesions of the abdominal viscera to the defect site.22 This is just one of 
many concerns that are currently being addressed in research. 
As mentioned previously, commonly used biomaterials are 
polytetrafluoroethylene (PTFE) and polypropylene (PP).  PTFE is a hydrophobic, 
non-biodegradable polymer that is utilized clinically when formed into a fiber mesh.21  
By adjusting the crosslink density of the polymer chains, one can ideally alter the 
adhesive and tissue ingrowth properties of the mesh; as is done with the Gore-Tex 
Dual mesh.21 This mesh’s bilayer design has a lower layer with a mesh size of 3µm 
and is meant to restrict tissue ingrowth, where as, the upper layer has a mesh size of 
greater than 100µm and is meant to provoke tissue ingrowth.  In a study by Gonzalez 
et al, it was found that this change in mesh size does significantly affect tissue 





light of this, other studies have shown that this design still has a high rate of 
recurrence, infection and inflammatory response.27 
Polypropylene on the other hand is a slightly less hydrophobic, non-
biodegradable polymer.  It is formed into meshes that contain macropores as opposed 
to the micropores of the PTFE.  These macropores help to trigger tissue ingrowth 
thereby improving the surgical integrity and strength of the implant.21, 22 
Nevertheless, PP has no natural defense for adhesion formation.  Therefore, the use of 
non-adhering agents such has hyaluronic acid and carboxymethylcellulose in addition 
to the PP is currently being investigated.22, 28 These glycosaminoglycans not only 
reduce the number of binding sites available on the PP, they also carry a charge, 
which can affect cell binding.  An overall advantage of the PP grafts is that they have 
a decreased risk of infection and inflammation when compared to the PTFE grafts.27  
 
2.4 Tissue Engineering Approaches to Treat Defects 
To construct more ideal devices, tissue engineering approaches are being 
applied.  By using engineering methodologies to study the structure-function 
relationship inherent in normal and pathological mammalian tissues, one can create 
biological substitutes to restore, maintain or improve the tissue function.8 Only 
though the combination of the functional biology of the system with the systems 
interaction characteristics can methods or tissues be produced that can replicate or 
improve that found naturally.  This approach began in the late 1880s with xenografts 






2.4.1 First Generation Drawbacks 
While each current hernia solution has different limiting factors, one that 
holds true for all current treatments is that there is a presence of an inflammatory 
response after implantation.  In the inflammatory response blood fills the defect, 
allowing proteins to form a provisional matrix, providing a scaffold to facilitate 
wound healing by helping resolve and reorganize incoming cells, proteins and 
signals.  Once this has occurred, acute inflammation begins with the infiltration of 
fluid, plasma proteins and leukocytes.  Following acute inflammation is the formation 
of granulation tissue, which is characterized by the proliferation of capillaries and 
fibroblasts.  However, when the inflammatory stimuli persists chronic inflammation 
results; which is characterized by the presence of macrophages, monocytes, and 
lymphocytes with vascularization beginning to occur.29 Finally, fibrous tissue is 
formed when foreign body giant cells incorporate into the granulation tissue.29  
The degree to which this inflammatory response occurs is responsible for how 
well the defect heals.  Wound infection can profoundly affect this response, thus 
making it essential to treat and prevent.  It has been reported that chronically draining 
sinuses will sometimes develop after a surgical procedure, become infected and cause 
complications; one complication being recurrence.5, 9, 10  
Therefore current technologies attempt to control not only this response but 
also wound infection and have been successful to a degree.  An implant’s topography 
has a significant influence on the extent to which the foreign body reaction occurs and 
consequentially the amount of fibrous scar tissue formed.  Advances in processing 





topographies to control cell infiltration.  One example would be the choice of a 
porous implant (natural or synthetic) that would incorporate more cells during the 
inflammatory response than a non-porous material.   
 
2.4.2 The Tissue Engineering Solution: Muscle Regeneration 
For hernia repair an ideal cell population would be the skeletal muscle 
progenitor cell: the satellite cell.  This would facilitate skeletal muscle regeneration as 
opposed to fibrous scar formation.  However, since satellite cells are not present in 
the prosthesis previous to implantation, they must migrate and compete with the 
granulation tissue and foreign body giant cells to enter the matrix.  With such an 
inadequate number of satellite cells available compared to the competing cells, the 
musculature is replaced almost solely by fibrous scar tissue as opposed to skeletal 
muscle.29, 30 Regenerating the skeletal muscle in the defect could ultimately restore 
function and decrease the hernia recurrence.  To create the ideal implant, the 
development and regeneration processes of skeletal muscle must first be understood. 
During muscle development mononuclear cells, called myoblasts, align 
parallel to one another and fuse to produce multinucleated myotubes.  The myotubes 
then undergo a maturation process, during which they become innervated and 
vascularized, resulting in the myofiber structure.31 Myofibers are bundled parallel to 
one another by aponeuroses to form functional skeletal muscle.  When electrically 
stimulated these bundles contract simultaneously, leading to the most distinctive 





Muscle regeneration is a slightly more complicated process as it involves 
satellite cells.  These mononuclear cells are present in skeletal, smooth and cardiac 
muscles.  In skeletal muscle specifically, they reside between the basal lamina and the 
existing myofiber it encapsulates.32-34 While the cells appear to be associated with the 
specific myofiber, this is not the case, as is shown by the presence of a gap between 
the plasma membrane of the myofiber and the membrane of the satellite cell.  This 
gap can range in size from 15-60nm with little protrusion of the basal lamina into the 
space.  It is possible that this disassociation is the key to the mobility of these cells.31 
The ability to migrate is vital, as the cells are found disbursed randomly throughout 
the myofiber with which they reside and are not always found in the same density in 
all skeletal muscles.31 Regardless of the reason for the defect, whether it be trauma, 
injury or disease, the process for regenerating muscle does not change.31 
When trauma to the musculature occurs, the available satellite cells become 
activated and migrate to the site of the defect and begin proliferating.  The newly 
produced cells have two options: to replenish the satellite cells reserve and return to 
quiescence or remain activated and migrate to the site of the defect.  If the second is 
the cells fate, it will differentiate into a myoblast and align parallel with each other 
and the remaining myofibers, as was done in muscle development.  Fusion begins and 
the resulting myotubes undergo the maturation process, becoming functioning 
myofibers.  To utilize this process current studies are focused on defining cell 
signaling pathways, migration, attachment, proliferation and differentiation of several 






2.4.3 A Novel Construct 
Polymeric scaffolds allow researchers and clinicians to control the properties 
of the repair meshes that are used.  The newest front in tissue engineering is the use of 
biodegradable polymers.  Most clinically used biodegradable polymers degrade into 
acidic products.  This creates an environment that elicits an inflammatory response 
and limits tissue healing.  By using EHD, a novel construct can be created which will 
degrade into neutral products, decreasing the inflammatory response and creating a 
better environment for tissue healing. 
A two-layer design will be used to develop this construct.  A layer of porous 
EH scaffold will be created and implanted facing the abdominal wall.  This scaffold 
will provide the structural stability for the construct, serve as a delivery vehicle for 
different proteins and provide an area for muscle regeneration to occur.  By altering 
the porosity of this layer, the tissue ingrowth, proteins delivery rate and possibly the 
degradation rate of the implant can be controlled.  However, to address the concern of 
adhesions from the peritoneal tissue and abdominal viscera the EH scaffold will be 
coated with a film of poly(ethylene glycol) (PEG).  PEG is currently used in clinical 
implants and has been shown to prevent the attachment of different cell types; this 
coating would be in contact with the underlying fascia on the peritoneal surface.  
Overall this construct would create an environment were skeletal muscle can integrate 
freely into the EH scaffold while the PEG coating would significantly decreasing the 
number of adhesions from the peritoneum and abdominal viscera.   
The work presented in this study addresses the initial stages of developing the 





with the scaffold were studied.  Once these had been established, further tests were 
performed to determine the interactions between the IGF-1 protein, myoblastic cell 










The objective of this project was to determine the feasibility of 5-ethyl-5-
(hydroxymethyl)-β,β-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD) networks as a 
biomaterial for abdominal wall hernia repair.  Incisional hernias are a common 
clinical problem occurring in up to ten percent of all patients undergoing abdominal 
incisions.  Current repair techniques involve the placement of a prosthetic 
biomaterial, xenografts, or allografts.  Despite these techniques, the incidence of 
hernia recurrence is in excess of ten percent.  This high recurrence rate is due to many 
things including the use of non-biodegradable scaffolds and fibrous scar tissue 
formation.  Therefore we hypothesize that developing a biodegradable biomaterial 
that can exhibit mechanical properties similar to skeletal muscle while incorporating 
myoblastic cells for skeletal muscle regeneration would be advantageous for hernia 
repair strategies. 
The novel property of the EH biomaterial is that it lacks the carboxyl groups 
in other biodegradable polymers, producing byproducts that are neutral as it degrades.  
This prevents additional premature degradation of the scaffold due to high acidity and 
decreases the inflammatory response of skeletal muscle tissue surrounding the 
implant.  With such desirable degradation qualities, adding a cellular component to 
this scaffold would create a functional biomaterial specific to abdominal wall hernia 





This study investigated the initial steps of creating an EH scaffold in an 
effort to develop a novel EHD based hernia repair construct.  To begin, the 
mechanical properties of the radically crosslinked EH networks were determined by 
studying the effects of increasing initiator concentration on the complex.  Next, the 
cellular interactions between the network and a myoblastic cell population were 
established by investigating the effects of increasing initiator concentration on 
myoblastic cell attachment.  Then, to ensure that the IGF-1 protein signaling was 
unaffected by the scaffold, the effect of increasing IGF-1 concentrations in the growth 
media on cell proliferation was tested on attached myoblastic cells.  Finally, to 
determine the ability of the EH scaffold to serve as a delivery system for IGF-1, the 
effects of increasing the concentration of absorbed IGF-1 on release and myoblastic 
cell proliferation were characterized.   
 
3.2 Materials and Methods 
3.2.1 Materials 
 Benzoyl peroxide (BP), N,N-dimethyl-p-toluidine (DMT), 5-ethyl-5-
(hydroxymethyl)-β,β-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD) and bovine 
serum albumin (BSA) were obtained from Sigma-Aldrich (Milwaukee, WI, USA).  
Reagent grade acetone was purchased from Fisher Scientific (Pittsburgh, PA, USA).  
F-10 ham media (F-10), fetal bovine serum (FBS), penicillin/streptomycin 
(Pen/Strep) and trypsin/EDTA were received from Invitrogen (Carlsbad, California, 





USA).  Recombinant human insulin-like growth factor-1 was acquired from R&D 
Systems (Minneapolis, MN, USA).  
 
3.2.2 EH Network Synthesis 
EH sheets were fabricated in a glass plate mold.  To assemble this mold, 
capillary tubes were secured onto one of two glass plates using vacuum grease.  
Together, the plate and capillaries made up the walls and bottom of a rectangular 
well.  Once this was done, a 0.81 M stock solution of BP in acetone was prepared.  
Working solutions were subsequently made from this stock based on the desired 
fabrication parameters.  EHD monomer was then mixed with the working initiator 
solution until one phase was present.  The accelerant DMT was added to the solution 
at a concentration of 0.5µL / g of EHD monomer.  The solution was mixed again and 
poured into the well of the previously prepared plate.  A second plate was used to 
cover the solution and the system was placed in an oven at 30°C for 20min. A 














































Figure 1. (a) Chemical structure of the monomer 5-ethyl-5-(hydroxymethyl)-
β,β-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD). (b) Chemical structure of 
the resulting crosslinked EH networks. (c) An EH network sheet made with 
0.58M BP solution. 
 
3.2.3 Skeletal Myoblast Isolation and Harvest 
Skeletal muscle was harvested and isolated from the hind limbs of Wistar 
Hannover GALAS rats.  Once the muscle was removed, it was rinsed three times with 
F-10 Ham media containing 10% Pen/Strep, diced, and then digested in 10mL of 
collagenase P solution for 2 hours at 37°C and 5% CO2.  After this time, 100µL of 





into the incubator for 30min at 37°C and 5% CO2.  The trypsin and collagenase P 
solution was neutralized with 22mL of growth media, composed of F-10 Ham media 
containing 10% FBS and 1% Pen/Strep.  The cell suspension was passed through 
three filters with 100µm, 70µm and 40µm mesh sizes respectively.  The remaining 
cells were spun down and the pellet was resuspended in growth media.  This was 
done twice more: once with growth media and once with F-10 Ham media only.  The 
resulting suspension was plated on a T-25 culture flask and was placed in the 
incubator at 37°C and 5% CO2.  The growth media was changed the day after harvest.  
At day 3 the cells were passaged and reseeded on a new T-25 culture flask.  Growth 
media was changed again at day 6 and finally on day 8 the cells were twice washed 
with PBS, trypsinized, and seeded according to the study parameters. 
 
3.2.4 Dynamic Mechanical Analysis 
 The mechanical properties of EH networks were analyzed by dynamic 
mechanical analysis, reflecting the mechanical forces experienced in the abdominal 
wall.  Five different networks were formed using initiator solution concentrations of 
0.08, 0.15, 0.23, 0.48 and 0.81M.  During fabrication 2.25mL of the desired initiator 
solution was used for every 2.0g of EHD monomer.  The resulting sheets were cut 
into 13mm x 30mm rectangles.  Using the Q-800 dynamic mechanical analyzer (TA 
Instruments, New Castle, Delaware) the samples were placed in the single cantilever 
clamp and held isothermally at 37°C.  One end of the network was then oscillated 





run with a sample size of 6 and the values for the complex modulus were reported as 
a mean and standard deviation of these samples at a frequency of 10Hz. 
 
3.2.5 Myoblastic Cell Compatibility 
Myoblastic cell attachment was investigated on EH networks that were 
formed using 0.75mL of either 0.34M or 0.58M initiator solution for every 2.0g of 
EHD.  These resulting networks were cut into disks with a diameter of 2.0cm.  They 
were subsequently washed three times for 15min each with phosphate buffer saline 
solution (PBS), acetone and PBS again, and then they were sterilized by exposure to 
UV light overnight.  Each disk was placed in a 12 well plate.  Stainless steel inserts 
were fabricated by cutting 1.5cm sections from a ¾” stainless steel polished pipe 
purchased from Stainless Steel Stock (Friend, NE).  These inserts were filed down 
until the edges were smooth, washed thoroughly and sterilized through autoclaving.  
They were then placed onto the network to prevent them from floating in the culture 
media.  A myoblastic cell population was seeded onto the center of the EH disks at a 
seeding density of 100,000 cells per network.  After 4 and 6h the disks were washed 
twice with PBS and the remaining cells were lifted with trypsin/EDTA and counted 
using a hemacytometer. 
 
3.2.6 Dosed IGF-1 Induced Myoblastic Cell Proliferation 
To examine the effect of EH networks on IGF-1 signaling, skeletal muscle 
cells were isolated and networks made from the 0.58M initiator solution were 





attachment before testing for cellular proliferation.  After 48h, the growth media was 
changed and IGF-1 was added at concentrations of 0ng/mL (control group), 10ng/mL 
and 15ng/mL of IGF-1.  All media was supplemented with FBS to provide proteins 
vital to the cell attachment.  At Day 0, when the experimental media was added, it 
was found that there were 0.1x106 ± 0.07x106 cells per disk.  After 3 and 5d the cells 
were lifted and counted using a hemacytometer.  This experiment was done in 
triplicate and the values are reported as the mean and standard deviation of the total 
number of cells for each group. 
 
3.2.7 Absorbed IGF-1 Release Profile and its Effect on Myoblastic Cell Proliferation 
In order to determine the activity of IGF-1 absorbed on the surface of EH 
networks, IGF-1 was physically adsorbed onto the network and the IGF-1 release and 
myoblastic cell proliferation was characterized.  IGF-1 powder was reconstituted in 
PBS with 0.1% BSA to a concentration of 100µg/mL.  Solutions of the IGF-1 stock 
were diluted to 10ng/mL, 50ng/mL and 150ng/mL.  1mL of the IGF-1 working 
solutions was added to the surface of the network and was allowed to evaporate 
overnight in a sterile laminar flow hood to physically adsorb the IGF-1.  Once dry, 
2mL of fresh PBS was added to each network and the networks were placed in the 
incubator at 37°C and 5% CO2.  At 0.25, 0.5, 0.75, 1, 2, 4, 6, 12, 24 and 48h a 300µL 
sample was removed and fresh PBS was added to maintain total volume.  All sample 
aliquots were stored at 4°C until analysis.  The samples were analyzed using a Human 
IGF-I Quantikine ELISA Kit (R&D Systems, Minneapolis, MN).  To investigate the 





disks with growth media being changed on day 3.  All media was supplemented with 
FBS as was done in the previous proliferation study.  After 3 and 5d the cells were 
lifted and counted using a hemacytometer.  Both studies were done in triplicate and 
the values were reported as the mean and standard deviation of the absolute amount 
of IGF-1 and the percent of loaded IGF-1 released from the network, as well as the 
total number of cells on each network respectively.  
 
3.2.8 Statistical Analysis 
Statistical analysis was performed on all data using an ANOVA and Tukey’s 
pairwise comparison tests. 
 
3.3 Results 
3.3.1 Dynamic Mechanical Analysis 
In this mechanical study, the frequency at which the sample was oscillated 
was varied between 1 and 100hz.  Initial data analysis displayed that this material had 
a complex modulus that had less than 8% variance across the entire frequency range.  
Therefore reported values were chosen from the middle of the experimental range at 
10Hz to eliminate any end effects.  Figure 2 shows that the complex modulus was 
found to be statistically similar for all networks made from BP solutions between 0.07 
and 0.48M.  However, comparison of the experimental groups that contained samples 
made from the 0.07 and 0.81M BP solutions show that the complex modulus 
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n = 6, p < 0.05
 
Figure 2.  Complex modulus as a function of initiator concentration.  A 
frequency sweep of 1-100Hz was run on a Q-800 dynamic mechanical analyzer 
(TA Instruments) with parameters of 37°C and 15µm amplitude.  Results for 
10Hz are reported. 
 
3.3.2 Myoblastic Cell Attachment 
To investigate the biocompatibility of the EH scaffolds, myoblastic cell 
attachment was tested.  Figure 3 demonstrates that when comparing the 0.34 
and 0.58M BP networks, there is a slight increase in myoblastic cell attachment 
as the initiator content is increased.  However, upon closer study of the results 
this trend was found to be insignificant.  It was also found that the percent of 
myoblastic cells attached to the experimental group and the tissue culture 
polystyrene (TCPS) were statically similar at all time points; showing that the 


























n = 3, p < 0.05
 
Figure 3.  Myoblastic cell attachment on EH networks with varied initiator 
concentrations.  All groups were found to be statistically similar. 
 
3.3.3 IGF-1 Induced Myoblastic Cell Proliferation 
 To increase cell proliferation and ultimately cell number, IGF-1 was added to 
the culture media at concentrations of 0ng/mL (control group), 10ng/mL and 
15ng/mL.  As mentioned above, cells were allowed to attach to the EH network for 
48h prior to IGF-1 addition; therefore all results were normalized to data taken on the 
day of IGF-1 addition (Day 0).  In Figure 4, at day 3, the cell numbers for the control, 
5ng/mL and 10ng/mL groups were as follows: 0.65x106 ± 0.10x106, 0.61x106 ± 
0.11x106 and 0.64x106 ± 0.13x106.  It was found that there was no significant 
difference between all groups at day 3.  However, by day 5 the groups containing 
growth media supplemented with IGF-1 had significantly more cells than the control 
group: the values for the control and experimental groups were 0.65x106 ± 0.17x106, 
1.0x106 ± 0.34x106 and 1.1x106 ± 0.28x106 respectively.  While there were no 





displays the result that the supplementation of IGF-1 to the growth media increases 




























n = 3, p < 0.05
* *
 
Figure 4. Total number of cells attached to EH networks after 3 and 5d.  It was 
shown in this study that only the experimental IGF-1 groups at day 5 were 
statistically different. 
 
3.3.4 Absorbed IGF-1 Release Profile 
To investigate the use of this material as a delivery device, IGF-1 was 
physically adsorbed onto the EH surface and allowed to release into fresh PBS over 
time.  To obtain release profiles of the IGF-1 three concentrations of 10ng, 50ng, and 
150ng were adsorbed onto the network and release was characterized over 48h.  
Figure 5a displays the absolute amount of IGF-1 released. The 50ng and 150ng 
loading groups released 16 ± 0.32ng and 17 ± 0.12ng of IGF-1 respectively over this 
time period.  These two groups follow a similar trend and are significantly similar for 
all point except 2h and 48h.  The 10ng loading group however, released 1.7 ± 





at all time points as was expected.  However, as a comparison, Figure 5b shows that 
when you look at the percent of loaded IGF-1 released there is a clear trend.  The 
50ng loading group released a significantly higher percent of IGF-1 than both the 
10ng and 150ng loading group after 48h.  Moreover, the 10ng loading group released 
a significantly higher percent of IGF-1 than the 150ng loading group.  The values for 
these percents after 48h were 32 ± 0.64%, 17 ± 0.29% and 11 ± 0.081% IGF-1 loaded 
respectively.  These networks were able to sustain the release of structurally intact 














































































n = 3, p < 0.05
 
(b) 
Figure 5.  (a) Total IGF-1 released from the surface of the EH network.  The 
10ng loading group released a significantly lower amount of IGF-1 than the 
50ng and 150ng loading groups.  The 50ng and 150ng groups released 
statistically similar amounts of IGF-1 at all time points except for 2 and 48h.  At 
these time points the 150ng loading group released significantly more IGF-1.  
(b) Percent IGF-1 released from the surface of the EH network.  The 10ng 
loading group released a significantly higher percent of the loaded IGF-1 than 
the 150ng loading group.  The 50ng group released the highest percent of the 
loaded IGF-1 and was statistically different from both the 10ng and 150ng 






3.3.5 Adsorbed IGF- 1 Induced Myoblastic Cell Proliferation 
To investigate the functionality of the adsorbed IGF-1, cells were attached to 
the loaded networks and proliferation was measured.  It was found, in Figure 6, that 
the 50ng and 150ng loaded networks had significantly more cells attached to the 
networks than either the 10ng loading group or the control at day 3.  By day 5 all 
groups were shown to be statistically similar.  Also, the control at day 5 was 
statistically higher than at day 3, showing a slower increase in cell numbers than the 



























n = 3, p < 0.05
* *
 
Figure 6.  Total number of cells attached to IGF-1 loaded EH 
networks after 3 and 5d.  It was shown in this study that only the 
networks that contained 50ng and 150ng of IGF-1 had 
significantly more cells attached at day 3 than the 10ng and 
control groups.  It was also found that by day 5 all groups 
statistically similar cell numbers. 
 
3.4 Discussion 
In this study, we hypothesize that developing a biodegradable biomaterial that 





myoblastic cell signaling will increase skeletal muscle regeneration within a hernia 
defect and would be advantageous for hernia repair strategies.  Specifically, 
fabrication parameters of the EH network as well as its biological function were 
investigated; mechanical strength, cellular attachment, IGF-1 induced proliferation, 
IGF-1 release and cellular proliferation upon a loaded scaffold were all examined.  
The results of these studies showed the ability of an EH scaffold to function as a 
portion of a viable clinical construct for abdominal hernia repair.   
Firstly, the mechanical properties of the crosslinked network were studied by 
investigating the effects of increasing initiator concentration on the complex modulus.  
We hypothesized that by increasing the BP content the mechanical properties, 
specifically the complex modulus, would increase.  However, it was found that over 
the range of networks made with 0.08 to 0.48M BP solutions there was no significant 
effect on the complex modulus.  In this range of initiator concentrations, the 
additional radicals in the system did not significantly change the crosslink density; 
therefore the increase in initiator content had no effect on the mechanical properties.  
When looking at the effects from 0.08 to 0.81M BP, however, the complex modulus 
decreased significantly.  The data shows that increasing the amount of initiator to this 
concentration not only increases the number of free radicals formed in the monomer 
solution, but it also increases the probability that the radicals will encounter each 
other or that cyclic polymer chains will be formed.  These phenomena decrease the 
number of radicals and monomers that are participating in the crosslinking, thus 
lowering the complex modulus.  Current clinical implants have higher mechanical 





initial mechanical testing has shown that the modulus of this material is still 
significantly higher than abdominal wall skeletal muscle, which has reported young’s 
modulus values of 42.5 ± 9.0kPa in the transverse plane and 22.5 ± 2.6kPa in the 
sagittal plane.21 Therefore to achieve more desirable mechanical properties porous 
scaffolds will ultimately be used. 
To investigate the biological functionality of the network, specifically the 
cellular interactions, the effects of increasing initiator concentration on the myoblastic 
cell attachment was tested.  The myoblastic cells were expected to have a similar 
percent attachment to the EH networks as the tissue culture polystyrene control.  It 
was found that at both time points the 0.58M BP system had a slightly higher percent 
of myoblastic cell attachment than the 0.34M BP system, however closer 
investigation showed that all groups performed statically similar at both 4 and 6h.  It 
has been shown in previous work that the 0.58M BP solution reacts more completely 
during network formation, leaving behind less toxic unreacted materials.22 This 
increase in unreacted materials from the 0.58M BP system to the 0.34M BP system 
could have resulted in the decrease in attached cells that was observed in this study.  
Therefore, the 0.58M BP formulation was used for all other studies.   
Protein interactions, specifically IGF-1 signaling pathways, were investigated 
by determining the effects of increasing the IGF-1 concentration in the culture media 
on cell proliferation.  It was expected that IGF-1 would retain its signaling pathways 
and increase the proliferation of attached myoblastic cells.  10ng/mL and 15ng/mL of 
IGF-1 were added to the culture media everyday for 5d.  It was found that at day 3, all 





and 15ng/mL group had significantly more cells that the control group but 
significantly similar cell numbers to each other.  This indicates that repeat exposure to 
the IGF-1 had a long-term effect on the cell proliferation.  It also shows that 
increasing the concentration from 10ng/mL to 15ng/mL did not have a significant 
effect on the cell proliferation perhaps due to the small difference in concentrations.  
This study demonstrates that the EH network does not affect the myoblastic cell’s 
ability to utilize the IGF-1 protein and increase proliferation. 
To be effective, the EH scaffold should be able to deliver the IGF-1 protein 
and enhance the IGF-1 signaling in vivo.  Therefore, the release rate of adsorbed IGF-
1 from the network must be characterized.  The effect of physically adsorbing 
increasing concentrations of IGF-1 on total IGF-1 released into PBS over time was 
measured.  10ng, 50ng and 150ng of IGF-1 were adsorbed onto the network and 
release was characterized over 48h.  These loading values correlate with the total 
amount of IGF-1 added over the 5d period in the first proliferation study.  It was 
expected that similar trends and percents released would be seen over the time period, 
however this was not the case.  The 10ng group showed an increase in release then 
began to level off around 2h, where it settled at 1.7 ± 0.029ng or 17.0 ± 0.29% of the 
loaded IGF-1 at 48h. While the absolute amount of IGF-1 released was significantly 
lower than both of the other groups, this group released the second highest percent 
release.  The release from the 50ng and 150ng groups was sustained until after 12h.  
The final amounts for these groups were 16.0 ± 0.32ng and 17.0 ± 0.12ng 
respectively.  This correlates to 32.0 ± 0.64% and 11.0 ± 0.081% of the loaded IGF-1 





statistically similar amounts of IGF-1, for all points except for at 2h and 48h where 
the 150ng loading group had a higher release, they did not release similar percents.  
The 150ng loading group had the lowest percent release where the 50ng loading 
group released the highest percent of IGF-1.  All percent data groups were 
statistically different.  These results show that only a small fraction of the IGF-1 
adsorbed was released over this time period.  This may be a result of a structural 
change in the IGF-1 protein during the loading process.  If this is the case, these 
mutated proteins cannot be accounted for using the Elisa assay and can only be 
deemed functional though cellular tests.  However, this data does show that the 
network can be functionalized to release IGF-1 into the local environment, therefore 
showing its ability to deliver IGF-1 to native skeletal muscle in vivo.  
To determine if the IGF-1 that was on the network was still active, 
proliferation tests were preformed on the loaded disks.  In these tests, the effects of 
increasing adsorbed IGF-1 on the myoblastic cell population were studied.  It was 
found that the networks loaded with 50ng and 150ng of IGF-1 had significantly more 
cells than the control and 10ng loaded networks after 3d.  However, by day 5 all of 
the groups had become significantly similar.  These results coincide with the release 
study results.  The 50ng and 150ng loading groups showed significantly similar 
proliferation, which coincides with the release data.  The 10ng loading group, 
however, released significantly less IGF-1 and this was reflected in the cell numbers 
after 3d.  By day 5, there was no additional IGF-1 being released from any of the 





This data indicates a short-term increase in myoblastic cell proliferation with respect 
to absorbed IGF-1 concentration. 
This study, when compared to the previous IGF-1 induced proliferation study 
showed two different trends.  When myoblastic cells were exposed to lower 
concentrations of IGF-1 continuously there was a delayed increase on myoblastic cell 
proliferation.  However, when the same total amount of IGF-1 was added in a burst at 
one time point, the results were a short-term increase in myoblastic cell proliferation.  
Overall, a similar increase in cell proliferation was seen in both studies, with the 
adsorbed IGF-1 exhibiting an increase in proliferation sooner than IGF-1 in culture 
media. 
These studies suggest that the EH scaffold would be a favorable material that 
could be used to facilitate myoblastic cell attachment and proliferation.  When 
combined with the fabrication and degradation properties, these materials are very 
promising in the field of tissue engineering, more specifically for skeletal muscle 
engineering.  This work explores the scaffold parameters that are most desirable for 
skeletal myoblastic cell attachment and proliferation in an effort to advance 
abdominal wall hernia repair.  An abdominal wall hernia repair scaffold would have 
mechanical properties similar to skeletal muscle as well as be able to induce 
myoblastic cell attachment and proliferation.  From this study, we have found that the 
novel cyclic acetal biomaterial EHD could be used clinically to support the muscle, 
and along with the incorporation of IGF-1 onto the network surface, induce 







This work examined the ability of the novel cyclic acetal biomaterial EHD to 
function as an abdominal wall hernia repair implant.  To do this, tissue engineering 
principles were employed to test this material for mechanical and biological 
compatibility.  Mechanical properties of the material were tested, as well as cellular 
attachment, IGF-1 induced proliferation and adsorbed IGF-1 release and induced 
proliferation.  The results showed that these networks could be altered based on the 
concentration of initiator solution used during fabrication.  Also, the myoblastic cell 
population attaches to the networks similarly to the tissue culture polystyrene control 
and proliferate upon these networks in the presence of IGF-1.  Finally, it was 
determined that IGF-1 can be released from the network after adsorption and continue 
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